ENDS Cardiovascular System: Difference between revisions
Richardpruen (talk | contribs) →Nicotine: update links |
No edit summary |
||
| Line 67: | Line 67: | ||
(Jacob George, MD, Muhammad Hussain, MSc, Thenmalar Vadiveloo, PhD, Sheila Ireland, BSc, Pippa Hopkinson, BSc, Allan D.Struthers, MD, Peter T. Donnan, PhD, Faisel Khan, PhD, Chim C.Lang, MD | (Jacob George, MD, Muhammad Hussain, MSc, Thenmalar Vadiveloo, PhD, Sheila Ireland, BSc, Pippa Hopkinson, BSc, Allan D.Struthers, MD, Peter T. Donnan, PhD, Faisel Khan, PhD, Chim C.Lang, MD | ||
E-cigarette (EC) use is increasing exponentially worldwide. The early cardiovascular effects of switching from tobacco cigarettes (TC) to EC in chronic smokers is unknown. Meta-analysis of flow-mediated dilation (FMD) studies indicate 13% lower pooled, adjusted relative risks of cardiovascular events with every 1% improvement in FMD. | E-cigarette (EC) use is increasing exponentially worldwide. The early cardiovascular effects of switching from tobacco cigarettes (TC) to EC in chronic smokers is unknown. Meta-analysis of flow-mediated dilation (FMD) studies indicate 13% lower pooled, adjusted relative risks of cardiovascular events with every 1% improvement in FMD. | ||
*See additional comments: [https://www.sciencemediacentre.org/expert-reaction-to-the-vesuvius-study-comparing-the-cardiovascular-effects-of-smoking-and-vaping/ Science Media Centre] | |||
===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592370/ 2019: Electronic cigarettes and cardiovascular health: what do we know so far?]=== <!--T:15--> | ===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592370/ 2019: Electronic cigarettes and cardiovascular health: what do we know so far?]=== <!--T:15--> | ||